- Global Pharma News & Resources

Melanoma Treatment Market Stakes, Top Leaders, Industry Size, Segmental Analysis, Regional Share, Growth Potentials, New Technology, Future Updates And Upcoming Trends Till – 2026

Melanoma Treatment Market — Insights

The cancer of melanocytes— a type of pigment cells – is known as melanoma. A major factor causing this skin cancer is high exposure to ultraviolet rays. There are three types of melanoma that include, cutaneous, mucosal, and ocular. Cutaneous melanoma is the cancer of skin, mucosal melanoma of mucous membrane in the mouth and nasal passage, and ocular melanoma of eye. Early diagnosis and treatment can increase survival rate in melanoma. Melanoma spreads to other body parts as well, thereby increasing the complexity of treatment. Rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma. The condition is diagnosed with biopsy of any skin lesion.

Request Sample Copy of the Business Report:

Melanoma Treatment Market Taxonomy:

The global melanoma treatment market is segmented as follows;

By Melanoma Type:

  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Ocular Melanoma

By Therapy:

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Surgical Treatment
  • Pharmacological Treatment

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Melanoma Treatment Market: Drivers

Increasing prevalence of melanoma is expected to propel growth of the market. For instance, according to Cancer Research Institute, in 2016, there were around 76,000 people diagnosed with melanoma in the U.S. Moreover, increasing R&D of drugs for the treatment of melanoma is expected to boost growth of the global melanoma treatment market over the forecast period. For instance, drugs such as seviprotimut-L by Polynoma, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf by Roche and Genetech are under development for the treatment of cutaneous melanoma. Selumetinib by AstraZeneca is under development for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and was the first drug to receive The U.S. FDA approval. Moreover, immunotherapy drugs such as opdivo and keytruda received the U.S. FDA approval.

Increasing use of targeted therapy, which include BRAF inhibitors in the treatment of melanoma is also expected to boost growth of the market. Targeted therapy has low adverse effects compared to chemotherapy. Moreover, increasing adoption of combination therapies is also contributing to the market growth. Combination therapies have low side effects and offer better outcomes. Increasing focus on personalized medicine and anti-melanoma drugs is expected to boost growth of the market over the forecast period.

Melanoma Treatment Market: Restraints

Some of the major factors that hinder growth of the market include, high price of combination therapies and clinical trial with side effects.

To understand Research Methodology, please click

Melanoma Treatment Market: Regional Analysis

The market in North America is expected to account for the largest market share over the forecast period, owing to factors such as high prevalence of melanoma, favorable reimbursement policy, increasing per capita income, developed healthcare sector, and increasing R&D activities in the region for melanoma drugs. The market in Europe is driven by increasing cases of melanoma and R&D of new therapies. Moreover, Europe is expected to account for the second largest market share over the forecast period. Fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs is expected to lead to moderate growth of the market in Asia Pacific.

Melanoma Treatment Market: Competitive Landscape

Major players operating in the global melanoma treatment market include, Amgen Inc., Sanofi, Merck & Co. Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Polynoma LLC, AstraZeneca, Takeda Pharmaceutical Company, Genetech Inc., and Novartis AG.

Table of Content

Global Melanoma Treatment Market Research Report
Section 1: Global Melanoma Treatment Industry Overview
Section 2: Global Economic Impact on Melanoma Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Melanoma Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Melanoma Treatment Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Mar-2021